Clinical Trial Update: Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating low-dose teclistamab in newly diagnosed multiple myeloma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TECVAYLI (TECLISTAMAB-CQYV)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Multiple Myeloma, Newly Diagnosed | Phase 2 | Status: RECRUITING